-
Integrative Peptide Drug Development: Chemical Engineering, AI-Driven Design, and Cell-Penetrating Peptides -
Decoding Immune Dysregulation in Sepsis Through Extracellular Vesicles: A Path to Precision Medicine -
Nanoparticle Clearance and New Horizons in Engineered Drug Delivery -
Harnessing Pharmacokinetic Modeling to Develop a Long-Acting Subcutaneous HIV Treatment Platform for Young Children -
From Magnetic Moment to Magnetic Particle Imaging: A Comprehensive Review on MPI Technology, Tracer Design and Biological Applications
Journal Description
Pharmaceutics
- Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
- High Visibility: indexed within Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus / SciFinder, and other databases.
- Journal Rank: JCR - Q1 (Pharmacology and Pharmacy) / CiteScore - Q1 (Pharmaceutical Science)
- Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 16.3 days after submission; acceptance to publication is undertaken in 3.3 days (median values for papers published in this journal in the first half of 2026).
- Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
- Companion journals for Pharmaceutics include: Future Pharmacology, Journal of Pharmaceutical and BioTech Industry and Medicines.
- Journal Clusters-Pharmaceutical Science: Scientia Pharmaceutica, Marine Drugs, Pharmaceuticals, Pharmaceutics, Pharmacy, Future Pharmacology, Pharmacoepidemiology, Drugs and Drug Candidates and Journal of Pharmaceutical and BioTech Industry.
Latest Articles
E-Mail Alert
News
Topics
Deadline: 30 October 2026
Deadline: 30 November 2026
Deadline: 10 December 2026
Deadline: 31 December 2026
Conferences
Special Issues
Deadline: 10 July 2026
Deadline: 10 July 2026
Deadline: 10 July 2026
Deadline: 10 July 2026













